Skip to main content
Livermore
Livermore
ZHEN

Pinnacle Associates Ltd

SEC CIK
0000743127
Latest filing
Aug 3, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by Pinnacle Associates Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q2 2026)
202,440
Value
$17.2M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of CYTK by Pinnacle Associates Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026202,440$17.2M0.2%+25,378+14.3%AddedHolders
Q1 2026177,062$11.7M0.1%−13,937−7.3%ReducedHolders
Q4 2025190,999$12.1M0.2%−10,491−5.2%ReducedHolders
Q3 2025201,490$11.1M0.1%−7,037−3.4%ReducedHolders
Q2 2025208,527$6.89M0.1%−61,908−22.9%ReducedHolders
Q1 2025270,435$10.9M0.2%−15,097−5.3%ReducedHolders
Q4 2024285,532$13.4M0.2%+27,174+10.5%AddedHolders
Q3 2024258,358$21.6M0.4%+4,494+1.8%AddedHolders
Q2 2024253,864$13.8M0.2%−3,303−1.3%ReducedHolders
Q1 2024257,167$18.0M0.3%−1,191−0.5%ReducedHolders
Q4 2023258,358$21.6M0.4%−971−0.4%ReducedHolders
Q3 2023259,329$7.64M0.1%−11,032−4.1%ReducedHolders
Q2 2023270,361$8.82M0.2%−9,645−3.4%ReducedHolders
Q1 2023280,006$9.85M0.2%−4,739−1.7%ReducedHolders
Q4 2022284,745$13.0M0.3%−5,106−1.8%ReducedHolders
Q3 2022289,851$14.0M0.3%−10,295−3.4%ReducedHolders
Q2 2022300,146$11.8M0.3%−1,318−0.4%ReducedHolders
Q1 2022301,464$11.1M0.2%−13,728−4.4%ReducedHolders
Q4 2021315,192$14.4M0.2%−2,023−0.6%ReducedHolders
Q3 2021317,215$11.3M0.2%−12,180−3.7%ReducedHolders
Q2 2021329,395$6.52M0.1%+5,096+1.6%AddedHolders
Q1 2021324,299$7.54M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.